Meyka AI API is live for developers.Start building.
Advertisement
Penumbra, Inc.

Penumbra, Inc. (PEN) Stock Overview

Explore Penumbra, Inc.’s financial performance, market position, analyst ratings, and future outlook.

PENNYSE
HealthcareMedical - Devices
$320.53
$0.10(0.03%)
U.S. Market opens in 59h 16m
Advertisement

Penumbra, Inc. (PEN)

Meyka AI Score

Z

Key Financials

Market Cap12.6B
P/E Ratio73.51
EPS (TTM)$4.33
ROE0.12%
Fundamental Analysis

AI Price Forecasts

1 Month$348.28
3 Months$314.43
1 Year Target$280.73

PEN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Penumbra, Inc. (PEN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 40.03, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $280.73.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 73.51 and a market capitalization of 12.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.07%
5-Day Change
0.28%
1-Month Change
-1.06%
3-Month Change
-5.93%
6-Month Change
6.57%
Year-to-Date (YTD) Change
3.06%
1-Year Change
24.01%
3-Year Change
-0.44%
5-Year Change
15.21%
All-Time (Max) Change
675.84%

Contact Information

510 748 3200
One Penumbra Place, Alameda, CA, 94502

Company Facts

4,500 Employees
IPO DateSep 18, 2015
CountryUS
Actively Trading

Frequently Asked Questions